| Regulation of cell death protease caspase-9 by phosphorylation MH Cardone, N Roy, HR Stennicke, GS Salvesen, TF Franke, ... Science 282 (5392), 1318-1321, 1998 | 4286 | 1998 |
| Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer S Ivanov, SY Liao, A Ivanova, A Danilkovitch-Miagkova, N Tarasova, ... The American journal of pathology 158 (3), 905-919, 2001 | 833 | 2001 |
| Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy MHT Bui, D Seligson, K Han, AJ Pantuck, FJ Dorey, Y Huang, S Horvath, ... Clinical cancer research 9 (2), 802-811, 2003 | 826 | 2003 |
| Chromosomal translocation t (1; 19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor J Nourse, JD Mellentin, N Galili, J Wilkinson, E Stanbridge, SD Smith, ... Cell 60 (4), 535-545, 1990 | 774 | 1990 |
| Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. J Pastorek, S Pastoreková, I Callebaut, JP Mornon, V Zelník, R Opavský, ... Oncogene 9 (10), 2877-2888, 1994 | 652 | 1994 |
| Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression BE Weissman, PJ Saxon, SR Pasquale, GR Jones, AG Geiser, ... Science 236 (4798), 175-180, 1987 | 539 | 1987 |
| Incorporation of 3H-uridine and 3H-uracil into RNA: a simple technique for the detection of mycoplasma contamination of cultured cells EL Schneider, EJ Stanbridge, CJ Epstein Experimental Cell Research 84 (1-2), 311-318, 1974 | 524 | 1974 |
| Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer M Atkins, M Regan, D McDermott, J Mier, E Stanbridge, A Youmans, ... Clinical cancer research 11 (10), 3714-3721, 2005 | 519 | 2005 |
| HumanMN/CA9Gene, a novel member of the carbonic anhydrase family: Structure and Exon to protein domain relationships R Opavský, S Pastoreková, V Zelnı́k, A Gibadulinová, EJ Stanbridge, ... Genomics 33 (3), 480-487, 1996 | 487 | 1996 |
| Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes SV Ivanov, I Kuzmin, MH Wei, S Pack, L Geil, BE Johnson, EJ Stanbridge, ... Proceedings of the national academy of sciences 95 (21), 12596-12601, 1998 | 482 | 1998 |
| Human cell hybrids: analysis of transformation and tumorigenicity EJ Stanbridge, CJ Der, CJ Doersen, RY Nishimi, DM Peehl, ... Science 215 (4530), 252-259, 1982 | 463 | 1982 |
| Suppression of malignancy in human cells EJ Stanbridge Nature 260 (5546), 17-20, 1976 | 451 | 1976 |
| The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis K Dreijerink, E Braga, I Kuzmin, L Geil, FM Duh, D Angeloni, B Zbar, ... Proceedings of the National Academy of Sciences 98 (13), 7504-7509, 2001 | 437 | 2001 |
| Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. PJ Saxon, ES Srivatsan, EJ Stanbridge The EMBO journal 5 (13), 3461-3466, 1986 | 422 | 1986 |
| Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6 JM Trent, EJ Stanbridge, HL McBride, EU Meese, G Casey, DE Araujo, ... Science 247 (4942), 568-571, 1990 | 421 | 1990 |
| Human tumor suppressor genes EJ Stanbridge Annual review of genetics 24 (1), 615-657, 1990 | 392 | 1990 |
| Cancer stem cells contribute to cisplatin resistance in Brca1/p53–mediated mouse mammary tumors N Shafee, CR Smith, S Wei, Y Kim, GB Mills, GN Hortobagyi, ... Cancer research 68 (9), 3243-3250, 2008 | 359 | 2008 |
| Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney SY Liao, ON Aurelio, K Jan, J Zavada, EJ Stanbridge Cancer research 57 (14), 2827-2831, 1997 | 348 | 1997 |
| Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect … MC Goyette, K Cho, CL Fasching, DB Levy, KW Kinzler, C Paraskeva, ... Molecular and cellular biology 12 (3), 1387-1395, 1992 | 323 | 1992 |
| Transcriptional control of the tumor-and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? S Kaluz, M Kaluzová, SY Liao, M Lerman, EJ Stanbridge Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1795 (2), 162-172, 2009 | 306 | 2009 |
